Validation of first trimester screening for trisomy 21 in Singapore with reference to performance of nasal bone.

Fetal Diagn Ther 2012 15;32(3):166-70. Epub 2012 Jun 15.

Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore.

Introduction: The aim of this study is to describe the performance of first trimester screening (FTS) for trisomy 21 using maternal age, serum biochemistry and fetal nuchal translucency (NT) in a single center and to evaluate the effect of nasal bone on screening performance.

Material And Methods: In 12,585 singleton pregnancies, the NT and nasal bone were examined. The majority of these mothers also had their serum biochemical markers analyzed. Risk was computed using different combinations of maternal age, biochemistry, NT and nasal bone. Down syndrome cases were confirmed by karyotyping.

Results: There were 12,519 normal pregnancies, 31 with trisomy 21 and 35 with other chromosomal abnormalities. Without considering the nasal bone, the combined FTS detected 87.1% of trisomy 21 fetuses (false positive rate 5.1%), using 1:300 as the risk threshold, and this was further improved to 96.8% with the policy that classifies all fetuses with an absent nasal bone as high risk. Subgroup analysis showed that the detection rate would be 90.9%, with a false positive rate of 3.7%, if nasal bone was incorporated in the risk algorithm, compared to 81.8% and a false positive rate of 5.4% if it was not used.

Discussion: FTS is very effective in early detection of trisomy 21 in Singapore. The nasal bone is a useful marker that can substantially improve the screening performance.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000338656DOI Listing
April 2013
33 Reads

Publication Analysis

Top Keywords

nasal bone
32
false positive
12
positive rate
12
nasal
8
bone
8
trisomy singapore
8
maternal age
8
trimester screening
8
trisomy
5
trisomy fetuses
4
871% trisomy
4
detected 871%
4
bone combined
4
combined fts
4
fts detected
4
fetuses false
4
risk threshold
4
1300 risk
4
rate 51%
4
rate
4

References

(Supplied by CrossRef)

Nicolaides KH et al.
Prenat Diagn 2011

Lai FM et al.
Singapore Med J 1998

Bindra R et al.
Ultrasound Obstet Gynecol 2002

Spencer K et al.
Ultrasound Obstet Gynecol 1999

Snijders RJ et al.
Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998

Cicero S et al.
Lancet 2001

Nicolaides KH et al.
Ultrasound Obstet Gynecol 2007

Nicolaides KH et al.
Am J Obstet Gynecol 2004

Wald NJ et al.
J Med Screen 2003

Malone FD et al.
N Engl J Med 2005

Cicero S et al.
Ultrasound Obstet Gynecol 2003

Similar Publications